Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Prof Federico Pappalardo is Director of CardioThoracic and Vascular Anesthesia and Intensive Care at AO SS Antonio e Biagio e Cesare Arrigo in Alessandria and at AOU Maggiore della Carità in Novara, IT. Prof Pappalardo has been Associate Professor at Vita-Salute San Raffaele University, Milan, (2017-2020), where he worked as Director of the Cardiothoracic Intensive Care Unit (2009-2018) and the… View more
ESC 23: Economic Burden of CVD in the EU
Author(s): Christian Sohns , Philipp Sommer Added: 7 months ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801). CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are… View more

Heart Failure

Electrophysiology & Arrhythmia
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 5 months ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia
Author(s): Marco Metra , Elisabetta Dinatolo , Nicolò Dasseni Added: 3 years ago
Despite improvements in treatment, heart failure (HF) continues to have a progressive clinical course characterised by worsening of cardiac function and clinical condition, leading to a stage of advanced chronic HF. At this stage, the clinical picture is characterised by severe symptoms, frequent episodes of decompensation, poor quality of life and poor survival. Evidence-based medical treatments… View more

Heart Failure

Heterogeneous Populations
Pulmonary Hypertension in Heart Failure Patients
Author(s): Sriram D Rao , Srinath Adusumalli , Jeremy A Mazurek Added: 4 years ago
Heart failure (HF) remains one of the most common medical conditions worldwide, placing a continuously growing burden on healthcare providers. Within the HF population itself, the subset of patients who develop pulmonary hypertension (PH-LHD) has been identified as having a significantly higher morbidity and mortality.1 There are limited therapeutic options for PH-LHD and it often complicates the… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Tonje Thorvaldsen , Lars H Lund Added: 3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients… View more

Heart Failure
Telemonitoring in Heart Failure Management
Author(s): Ivo Planinc , Davor Milicic , Maja Cikes Added: 3 years ago
Heart failure (HF) affects more than 2% of the adult population worldwide; it is responsible for about 1 million hospitalisations per year in the US and it carries a high mortality risk.1 Recent population data indicate overall better survival rates, albeit with greater healthcare costs.1 Altogether, HF syndrome represents one of the biggest challenges to modern medicine, and places an enormous… View more

Imaging & Diagnostics

Heart Failure
Imaging in HFrEF
Author(s): Rebecca C Gosling , Abdallah Al-Mohammad Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Temporary Mechanical Circulatory Support in Acute Heart Failure
Author(s): Federica Jiritano , Valeria Lo Coco , Matteo Matteucci , et al Added: 3 years ago
Cardiogenic shock (CS) is a circulatory failure as a consequence of left, right or biventricular dysfunction.1 It leads to critical end-organ hypoperfusion due to primary cardiac dysfunction.1 Therefore, CS is not only a cardiac disease but also a multiorgan dysfunction syndrome involving the entire circulatory system, often complicated by a systemic inflammatory response syndrome.2 The goals of… View more

Heart Failure
AHA 23: 3 Trials That Will Change My Practice
Author(s): Dipti Itchhaporia Added: 4 months ago
AHA 23 - Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, US), interventional cardiologist and Past President of the American College of Cardiology (ACC) highlights the top three late-breaking science trials from the 2023 AHA Scientific Sessions with the potential to change medical practices.Trials discussed in detail include:SELECT: Semaglutide and Cardiovascular Outcomes in Obesity… View more

Anticoagulation

Standards & Guidelines